Join this meeting that will explore the assessment and treatment of adolescents presenting with gender dysphoria, with evidence for intervention with medical hormonal therapy. We aim to highlight potential issues for clinicians looking after adolescents and future clinical consequences for adults who have undergone early treatment as an adolescent. Also, learn the ethics and legality of treating children.
This meeting is aimed at medical clinicians to discuss the use of gonadotropin-releasing hormone (GnRH) agonists (more commonly known as hormone or puberty blockers) in transgender adolescents. The early use of blockers has been suggested as reversible but as treatment of this group increases, issues and challenges regarding fertility preservation and the effects of future gender reassignment surgery, cognitive and bone health have been highlighted.
This meeting will provide a balanced and informed discussion of the current practice affecting medical practitioners from urology, gynaecology, endocrinology and psychiatry looking after adolescents with gender incongruence.
Topics include:
*Please note we will need to check all GMC numbers of attendees to this meeting. Ensure you bring this with you, attendance may be denied otherwise.
The Urology Section would like to thank our Annual Sponsor KARL STORZ Endoscopy (UK) Ltd for their valued support of the entire 2021 to 2022 Academic Programme.
Please note that the scientific programme and content have not been influenced in any way by the sponsors.
Follow us on:
Facebook
Instagram
LinkedIn
Twitter
YouTube
Professor Seshadri Sriprasad, President, Urology Section, Royal Society of Medicine
Chair: Dr Abdul Lakhdar, Consultant Endocrinologist, Barts Health NHS Trust
Miss Pippa Sangster, Consultant Urological Surgeon and Andrologist, University College London Hospital NHS Foundation Trust and Mr Roland Morley, Consultant Urologist, Imperial College Healthcare NHS Trust
Dr Polly Carmichael, Consultant Clinical Psychologist, The Tavistock and Portman NHS Foundation Trust
Professor Gary Butler, Professor of Paediatric Endocrinology, University College London Hospitals NHS Foundation Trust
Professor Christina Richards, Lead Consultant Psychologist, The Tavistock and Portman NHS Foundation Trust
Dr Peter Hammond, Consultant Physician, Harrogate and District NHS Foundation Trust
Chair: Professor Seshadri Sriprasad
Professor Dominic Wilkinson, Professor of Medical Ethics, University of Oxford
Professor Susan Bewley, Professor of Women's Health, King’s College London
Dr Peter Dunne, Senior Lecturer, University of Bristol Law School
Chair: Professor Henrietta Bowden-Jones OBE, President and Council Member, Psychiatry Section, Royal Society of Medicine
Dr Melanie Davies, Consultant Obstetrician and Gynaecologist, University College London Hospitals NHS Foundation Trust
Dr Sania Latif, Clinical Research Fellow, University College London Hospitals NHS Foundation Trust
Miss Pippa Sangster
Dr Channa Jayasena, Reader and Consultant in Reproductive Endocrinology, Imperial College London
Chair: Mr James Bellringer, Consultant Surgeon, Parkside Private Hospital
Miss Tina Rashid, Consultant Urological Surgeon, Imperial College Healthcare NHS Trust (for) and Professor Mark-Bram Bouman, Plastic Reconstructive Gender Surgeon, Vrije University Amsterdam (against)
Chair: Mr Roland Morley
Dr Polly Carmichael, Miss Pippa Sangster, Professor Melanie Davies, Professor Susan Bewley and Dr Peter Dunne
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
Disclaimer: All views expressed at this event are of the speakers themselves and not of the RSM nor the speaker's organisations.
Registration for this event will close at 1:00am on 7 July 2022. Late registrations will not be accepted.
